云南高校图书馆联盟文献共享服务平台- HYPERPHOSPHATEMIA

HYPERPHOSPHATEMIA: 作品数：18被引量：77H指数：5; 导出分析报告; 相关领域：医药卫生更多>>; 相关作者：陈兰更多>>; 相关机构：厦门大学更多>>; 相关期刊：《World Journal of Gastroenterology》《World Journal of Gastrointestinal Pharmacology and Therapeutics》《Journal of Pharmacy and Pharmacology》《Chinese Medical Journal》更多>>; 相关基金：国家科技支撑计划国家自然科学基金更多>>

Sucroferric oxyhydroxide monotherapy for hyperphosphatemia in Indian chronic kidney disease patients undergoing hemodialysis:A phase IV,single-arm,open-label study: 《World Journal of Nephrology》2025年第2期105-113,共9页M R Niranjan Sanjay Srinivasa Vibhanshu Gupta Anil K Bhalla Ankush Gaikwad Prajakta Wangikar Sachin Suryawanshi Priti Gajbe; BACKGROUND Hyperphosphatemia(HP)is a common complication in an advanced stage of chronic kidney disease(CKD)and is associated with cardiovascular issues,metabolic bone abnormalities and worsening of secondary hyperpar...; 关键词：Chronic kidney disease Dynulta™ HEMODIALYSIS HYPERPHOSPHATEMIA Iron-based phosphate binder Sucroferric oxyhydroxide

Doctor-led intensive diet education on health-related quality of life in patients with chronic renal failure and hyperphosphatemia被引量：13: 《World Journal of Clinical Cases》2022年第4期1217-1225,共9页Xian-Dong Feng Xue Xie Rui He Fang Li Gui-Zhong Tang; BACKGROUND Secondary hyperparathyroidism,renal osteodystrophy,and cardiovascular adverse events can occur if long-term hyperphosphatemia is not corrected,leading to the adverse prognosis of patients with chronic renal...; 关键词：Dietary education Chronic renal failure HEMODIALYSIS HYPERPHOSPHATEMIA Quality of life SATISFACTION

Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy被引量：1: 《World Journal of Cardiology》2021年第12期676-694,共19页Mouhamed Nashawi Mahmoud S Ahmed Toka Amin Mujahed Abualfoul Robert Chilton; The beneficial cardiorenal outcomes of sodium-glucose cotransporter 2 inhibitors(SGLT2i)in patients with type 2 diabetes mellitus(T2DM)have been substantiated by multiple clinical trials,resulting in increased interes...; 关键词：Sodium-glucose cotransporter 2 PHOSPHATE HYPERPHOSPHATEMIA CARDIOVASCULAR Canagliflozin DAPAGLIFLOZIN Empagliflozin ENDOTHELIAL

Analysis and Nursing Health Education of Current Status of Maintenance Hemodialysis Patients with Hyperphosphatemia被引量：1: 《Journal of Advances in Medicine Science》2020年第2期31-33,共3页Wenwen He Yingyi Bi Hongjiao Xu Liqian Gao Xing Zhao; Concerned about the current situation of hemodialysis patients'awareness of the problems related to dialysis complicated with hyperphosphatemia,further analyze the existing problems and causes,give targeted and indivi...; 关键词：HEMODIALYSIS HYPERPHOSPHATEMIA Nursing health education

Review of the diagnosis of gastrointestinal lanthanum deposition被引量：6: 《World Journal of Gastroenterology》2020年第13期1439-1449,共11页Masaya Iwamuro Haruo Urata Takehiro Tanaka Hiroyuki Okada; Lanthanum carbonate is used for treatment of hyperphosphatemia mostly in patients with chronic renal failure.Although lanthanum carbonate is safe,recently,lanthanum deposition in the gastrointestinal mucosa of patient...; 关键词：LANTHANUM CARBONATE HYPERPHOSPHATEMIA GASTROINTESTINAL endoscopy LANTHANUM phosphate Scanning electron microscopy Energy-dispersive X-ray SPECTROMETRY

Mineral and bone disorder and management in the China Dialysis Outcomes and Practice Patterns Study被引量：18: 《Chinese Medical Journal》2019年第23期2775-2782,共8页Jun Wang Brian A.Bieber Fan-Fan Hou Friedrich K.Port Shuchi Anand; This work was supported by grants from the Global support for the ongoing DOPPS Programs without restriction on publications by a variety of funders(For details see https://www.dopps.org/AboutUs/Support.aspx);Dr.Shuchi Anand is supported by U.S.National Institute of Diabetes,and Digestive and Kidney Diseases(No.NIDDK K-235K23DK101826-03);Dr.Jun Wang is supported by the National Natural Science Foundation of China(No.81470972).; Background:Despite a growing population of patients starting hemodialysis in China,little is known about markers of mineral bone disease(MBD)and their management.We present data on prevalence and correlates of hypocal...; 关键词：Mineral bone disease HYPERPHOSPHATEMIA HYPERPARATHYROIDISM China HEMODIALYSIS Dialysis Outcomes and Practice Patterns Study

Recuperation of severe tumoral calcinosis in a dialysis patient: A case report被引量：2: 《World Journal of Clinical Cases》2019年第23期4004-4010,共7页Lukas Westermann Lisa K Isbell Marie K Breitenfeldt Frederic Arnold Elvira Rothele Johanna Schneider Eugen Widmeier; BACKGROUND One of the common late sequela in patients with end-stage renal disease(ESRD)is the calcium phosphate disorder leading to chronic hypercalcemia and hyperphosphatemia causing the precipitation of calcium sal...; 关键词：End-stage RENAL disease RENAL replacement therapy-dialysis HYPERPARATHYROIDISM HYPERCALCEMIA HYPERPHOSPHATEMIA Tumoral CALCINOSIS Case report

Mineral and Bone Disorder and Its Association with Cardiovascular Parameters in Chinese Patients with Chronic Kidney Disease被引量：21: 《Chinese Medical Journal》2016年第19期2275-2280,共6页Chu Zhou Fang Wang Jin-Wei Wang Lu-Xia Zhang Ming-Hui Zhao; Background：Mineral and bone disorder （MBD）,especially hyperphosphatemia,is an independently risk factor for adverse prognosis in patients with chronic kidney disease （CKD）.However,CKD-MBD among Chinese population...; 关键词：Chronic Kidney Disease HYPERPHOSPHATEMIA Left Ventricular Hypertrophy Mineral and Bone Disorder Vascular Calcification

An Uncommon Potentially Fatal Complication in a Patient without Predisposing Factor Following Oral Bowel Preparation Commonly Used for Colonoscopy: 《Open Journal of Emergency Medicine》2016年第1期6-10,共5页Iris Wai Sum Li Ling Pong Leung Sik Hon Tsui; We described the case report of a patient presented with no known predisposing factor, generalized malaise with vomiting, locked jaw, perioral paraesthesia, carpopedal spasm and a positive Chvostek’s sign which resul...; 关键词：Symptomatic Hypocalcaemia HYPERPHOSPHATEMIA Sodium Phosphate Solution Bowel

Chitosan： A Desirable Candidate for Treating Hyperphosphatemia？: 《Journal of Pharmacy and Pharmacology》2016年第2期99-104,共6页Haisong Zhang Meng Yu Hailei Zhang; Non-absorbed macromolecular binders as sequestrants for phosphate ions offer an effective approach to treat hyperphosphatemia in ESRD （end-stage renal disease） patients. RenaGel has been an example with remarkable s...; 关键词：CHITOSAN phosphate binder hyperphosphatemia.

HYPERPHOSPHATEMIA